Countries AccessView catalog
Health

Health conditions and peptide research

Common conditions explained for physicians: what they are, standard treatment, and what peptide research has shown, with an honest evidence label.

Approved peptide drugsHuman trialsAnimal studies onlyWeak or mixed evidence

Cardiology

Atherosclerotic cardiovascular diseaseGLP-1s beyond weight: the hard-outcome trialsApproved peptide drugsICD-10 I25

Critical care and infection

SepsisThymosin alpha-1 after TESTS: two large negative trialsHuman trialsICD-10 A41.9

Dermatology

Hair loss (alopecia)Peptides and hair loss: copper, thymosin β4 and biomimetics against the evidenceWeak or mixed evidenceICD-10 L64–L65

Endocrinology and metabolism

ObesityGLP-1 drugs: a complete guide to semaglutide and beyondApproved peptide drugsICD-10 E66Severe primary IGF-1 deficiencyIGF-1 LR3 and mecasermin: the lab analog and the approved drugApproved peptide drugsICD-10 E34.3Growth hormone deficiencySermorelin: what it is, evidence and regulatory statusHuman trialsICD-10 E23.0HIV-associated lipodystrophyTesamorelin: the GHRH analog that did clear the FDAApproved peptide drugsICD-10 E88.1

Mental health

Alcohol use disorderSemaglutide and alcohol: three trials and a warning removedHuman trialsICD-10 F10

Neurology

Alzheimer's disease and dementiaGLP-1s, dementia and Alzheimer's: what EVOKE showedHuman trialsICD-10 G30

Oncology

Cancer: approved peptide drugsPeptides in oncology: the approved drugs already treating cancerApproved peptide drugs

Orthopedics and sports

Tendon injuriesBPC-157 in the laboratory: tendon, gut and blood vesselsAnimal studies only

Sexual health

Hypoactive sexual desire disorderSexual health peptides: a complete guide to PT-141Approved peptide drugsICD-10 F52.0

Sleep

InsomniaDSIP: what it is, sleep evidence and safetyWeak or mixed evidenceICD-10 G47.0

Educational content for health professionals. It does not replace clinical judgment or a consultation.